| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5844205 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 2016 | 8 Pages |
Abstract
Further studies focused on the outlined genes may be helpful to provide validated markers of BD treatment outcome.
Keywords
cAMP responsive element binding protein 1NMDAN-methyl-d-aspartateDSM-IVANKK1XBP1NTF3GSK3βETS1Grin2aDRD2NTRK2PTPRDDEP domain containing mTOR-interacting proteinGRIA2SLC6A4CREB1STEP-BDCHRNA7Grin2BmTORC1CNTNAP2CMFKCNJ2GRM4NRXN1LRRK2mLST8PFCPCCFDRmTORMAFIBDRASGRF1AMPAIBSBDNFMAPKbipolar disorderalpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acidstandard deviationPathway analysisleucine-rich repeat kinase 2CNSDiagnostic and Statistical Manual of Mental Disorders, 4th editionMarscentral nervous systembrain derived neurotrophic factorPharmacogenomicsminor allele frequencyprefrontal cortexGenome-wide association studyGWASfalse discovery rateNeurotrophin 3Mechanistic target of rapamycinMammalian target of rapamycin complex 1identity-by-descentTreatment responseX-box binding protein 1Single nucleotide polymorphismSNPGenemitogen-activated protein kinasesDEPTORglycogen synthase kinase 3 betadopamine receptor D2
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Chiara Fabbri, Alessandro Serretti,